3 Soaring Biotech Stocks to Watch in December [The Motley Fool]
Arrowhead Pharmaceuticals, Inc. (ARWR)
Last arrowhead pharmaceuticals, inc. earnings: 2/5 04:00 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.arrowheadpharma.com/investor-relations
Company Research
Source: The Motley Fool
3 Soaring Biotech Stocks to Watch in December This has been a banner year for three biotech stocks and their shareholders. All of them have soared in response to promising clinical trial results for some very different experimental therapies. If you're not sure why these stocks are among the biotech industry's top performers, let's review the highlights. Company (Symbol) Stock Price Gain in 09 Market Cap Arrowhead Pharmaceuticals NASDAQ:ARWR 88% $7.0 billion Adverum Biotechnologies NASDAQ:ADVM % $70 million Arqule NASDAQ:ARQL $. billion Data source: Yahoo! Finance. . Arrowhead Pharmaceuticals: RNA interference Arrowhead Pharmaceuticals stock has been rocketing higher this year thanks to encouraging clinical trial results for JNJ-989, a new type of antiviral therapy that interferes with the hepatitis B virus (HBV) as it tries to replicate itself. In the U.S., there could be more than a million people chronically infected with HBV, which raises their chances of developing severe liver p
Show less
Read more
Impact Snapshot
Event Time:
ARWR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARWR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARWR alerts
High impacting Arrowhead Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ARWR
News
- Arrowhead Pharmaceuticals Announces Topline Results from Part 2 of Phase 1/2 Study of ARO-C3 in Patients with IgA Nephropathy [Yahoo! Finance]Yahoo! Finance
- Arrowhead Pharmaceuticals Announces Topline Results from Part 2 of Phase 1/2 Study of ARO-C3 in Patients with IgA NephropathyBusiness Wire
- Arrowhead Pharmaceuticals Showcases Two Clinical-Stage RNAi-Based Candidates to Treat Obesity and Metabolic DiseasesBusiness Wire
- Hypertriglyceridemia Pipeline Market Research 2025: Comprehensive Review on 18+ Companies and 20+ Pipeline Drugs [Yahoo! Finance]Yahoo! Finance
- Arrowhead Pharmaceuticals Launches on Rare Disease Day New Patient-Centric Resources for Those Affected by Familial Chylomicronemia Syndrome (FCS) [Yahoo! Finance]Yahoo! Finance
ARWR
Earnings
- 2/10/25 - Miss
ARWR
Sec Filings
- 3/7/25 - Form 424B7
- 3/5/25 - Form 4
- 3/4/25 - Form 144
- ARWR's page on the SEC website